KOVO.V Kovo Healthtech Corp
- Market cap
- CAD 884K
- P/E
- -
- P/B
- 7.48x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is KOVO.V undervalued?
Graham numberThe Graham number of Kovo Healthtech Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Kovo Healthtech Corp fundamental analysis
No fundamental analysis for Kovo Healthtech Corp yet.
Kovo Healthtech Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Kovo Healthtech Corp
Kovo+ Holdings Inc. operates as a healthcare technology company in the United States. The company delivers various software solutions and services, including revenue cycle management, inpatient systems, and ambulatory and eHealth software; and credentialing and hourly services, as well as electronic health records. It also offers associated services, such as electronic claim process, eligibility for reimbursement verifications, and electronic remittance advice. In addition, …
Full company profileKovo Healthtech Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Kovo Healthtech Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | - | - | - | 3.02M | 5.90M | 10.9M | 10.0M | 10.6M | 10.0M | 7.94M |
| Operating Income | - | - | - | -1.04M | -1.23M | -791K | -3.52M | -3.24M | -3.42M | -4.42M |
| EBITDA | - | - | - | -416K | -1.73M | 459K | -3.34M | -3.09M | -9.89M | -5.51M |
| Net Income | - | - | - | -1.20M | -2.70M | -250K | -4.68M | -5.87M | -14.9M | -14.0M |
| EPS | - | - | - | -0.04 | -0.07 | -0.01 | -0.08 | -0.04 | -0.08 | -0.08 |
| Balance Sheet | ||||||||||
| Total Assets | - | - | - | 3.18M | 7.33M | 6.93M | 9.26M | 11.4M | 6.91M | 6.14M |
| Total Liabilities | - | - | - | 3.80M | 7.50M | 6.01M | 9.56M | 15.4M | 24.4M | 30.7M |
| Shareholders' Equity | - | - | - | -614K | -170K | 924K | -299K | -3.99M | -17.5M | -24.5M |
| Cash & Short-term Investments | - | - | - | 153K | 711K | 692K | 102K | 305K | 211K | 119K |
| Cash Flow | ||||||||||
| Operating Cash Flow | -15.0K | -34.0K | 286K | -461K | -1.00M | -420K | -717K | -3.98M | -2.66M | -3.15M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 165K | 163K | 348K | 429K | 140K | 3.00K | 0.00 |
| Free Cash Flow | - | - | - | -626K | -1.16M | -768K | -1.15M | -4.12M | -2.66M | -3.15M |
| Ratios | ||||||||||
| ROE | - | - | - | - | - | -27.1% | - | - | - | - |
| ROA | - | - | - | -37.7% | -36.8% | -3.6% | -50.6% | -51.6% | -215.9% | -227.5% |
| Net Profit Margin | - | - | - | -39.7% | -45.7% | -2.3% | -46.8% | -55.6% | -148.6% | -175.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Kovo Healthtech Corp dividends
Kovo Healthtech Corp has not paid dividends in the last 9 fiscal years.
Who owns Kovo Healthtech Corp
- Insiders 72.65%
- Institutions 0.00%
- Public & others 27.35%
- Shares outstanding 177M
- Free float 47.7M
Kovo Healthtech Corp company profile
- Company name
- Kovo Healthtech Corp
- Ticker
- KOVO.V
- ISIN
- CA50073R1073
- Exchange
- TSX Venture Exchange
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 79
- Fiscal year end
- December
- Address
- 1500 ? 850 2 St SW, Calgary, AB, Canada, T2P 0R8
- Phone
- 800 714 0308
- Website
- kovoplus.com
About Kovo Healthtech Corp
Kovo+ Holdings Inc. operates as a healthcare technology company in the United States. The company delivers various software solutions and services, including revenue cycle management, inpatient systems, and ambulatory and eHealth software; and credentialing and hourly services, as well as electronic health records. It also offers associated services, such as electronic claim process, eligibility for reimbursement verifications, and electronic remittance advice. In addition, the company provides printing and mailing, and group purchasing services. The company provides its solutions to medical practices, facilities, clinics, and hospitals. The company was formerly known as Kovo HealthTech Corporation and changed its name to Kovo+ Holdings Inc. in October 2024. Kovo+ Holdings Inc. is headquartered in Calgary, Canada.
Kovo Healthtech Corp management
4- Mr. Chris BurcChief Executive Officer
- Ms. Jeana K. NobleFounder & President · born 1968
- Mr. Matthew WoodinChief Financial Officer
- Ms. Denise PurvisVice President of Operations